AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 15208467 — intervention group
Group type: COMPARATOR
Intervention: QI-Therapy
Number of subjects: 1176
Study 15208467 — intervention group
Group type: COMPARATOR
Intervention: QI-Meds
Number of subjects: 1176
Study 12350480 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg dutasteride daily
Number of subjects: 4325
Study 12350480 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4325
Study 10546008 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate assay group
Number of subjects: 201
Study 10546008 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 201
Study 7606946 — intervention group
Group type: EXPERIMENTAL
Intervention: Music (M+)
Number of subjects: 49
Study 7606946 — intervention group
Group type: COMPARATOR
Intervention: Control (M-)
Number of subjects: 49
Study 2229286 — intervention group
Group type: EXPERIMENTAL
Intervention: Conjugated estrogens (0.625 mg/day; n = 7)
Number of subjects: 14
Study 2229286 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 7)
Number of subjects: 14
Study 860743 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensory integrative therapy
Number of subjects: 0
Study 860743 — intervention group
Group type: COMPARATOR
Intervention: Control children
Number of subjects: 0
Study 31124928 — intervention group
Group type: EXPERIMENTAL
Intervention: Benson relaxation method (BRM)
Number of subjects: 634
Study 31124928 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 634
Study 29183393 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic penehyclidine inhalation
Number of subjects: 864
Study 29183393 — intervention group
Group type: COMPARATOR
Intervention: Placebo (water for injection)
Number of subjects: 864
Study 26380437 — intervention group
Group type: EXPERIMENTAL
Intervention: Qingyuan Shenghua Decoction (QSD), one dose per day for 1 week
Number of subjects: 60
Study 24377215 — intervention group
Group type: EXPERIMENTAL
Intervention: Chen's needling therapy
Number of subjects: 84
Study 24377215 — intervention group
Group type: COMPARATOR
Intervention: Conventional needling therapy
Number of subjects: 84
Study 24377215 — intervention group
Group type: COMPARATOR
Intervention: Comparison between Chen's needling therapy and Conventional needling therapy
Number of subjects: 84
Study 21943482 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent intervention including e-learning, team training, introduction of electronic alcohol based hand rub dispensers and performance feedback
Number of subjects: 16
Study 21943482 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 16
Study 19930855 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes mellitus
Number of subjects: 590
Study 19930855 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined glucose intolerance (CGI)
Number of subjects: 590
Study 19930855 — intervention group
Group type: COMPARATOR
Intervention: Normal glucose tolerance, impaired fasting glucose (IFG), impaired glucose tolerance (IGT)
Number of subjects: 590
Study 16500485 — intervention group
Group type: EXPERIMENTAL
Intervention: Doppler tissue echocardiography-derived strain rate imaging
Number of subjects: 30
Study 16500485 — intervention group
Group type: COMPARATOR
Intervention: Control group (28 healthy volunteers; 20 women; 44 ± 10 years)
Number of subjects: 30
Study 12937051 — intervention group
Group type: EXPERIMENTAL
Intervention: Phototherapy with turquoise fluorescent lamp
Number of subjects: 0
Study 12937051 — intervention group
Group type: COMPARATOR
Intervention: Phototherapy with blue fluorescent lamp
Number of subjects: 0
Study 12380408 — intervention group
Group type: EXPERIMENTAL
Intervention: Depot medroxyprogesterone acetate (DMPA)
Number of subjects: 0
Study 12380408 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study 9529836 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine (300 micrograms for 5 weeks)
Number of subjects: 114
Study 9529836 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 114
Study 9529836 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 114
Study 8039530 — intervention group
Group type: EXPERIMENTAL
Intervention: MK-0434 (0.1-100 mg)
Number of subjects: 0
Study 2688711 — intervention group
Group type: EXPERIMENTAL
Intervention: High Flux Dialysis (HF)
Number of subjects: 20
Study 2688711 — intervention group
Group type: COMPARATOR
Intervention: Conventional Dialysis (CD)
Number of subjects: 20
Study 1002100 — intervention group
Group type: EXPERIMENTAL
Intervention: Contrapect (new antitussive principle)
Number of subjects: 0
Study 1002100 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 31677542 — intervention group
Group type: EXPERIMENTAL
Intervention: Osmometry
Number of subjects: 6
Study 31677542 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure‐volume (P‐V) curves
Number of subjects: 6
Study 28528395 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment of fractional CO2 laser therapy and hair growth factors
Number of subjects: 28
Study 28528395 — intervention group
Group type: COMPARATOR
Intervention: Hair growth factors alone
Number of subjects: 28
Study 25122150 — intervention group
Group type: EXPERIMENTAL
Intervention: Tadalafil treatment
Number of subjects: 405
Study 23638631 — intervention group
Group type: EXPERIMENTAL
Intervention: Oestradiol valerate/dienogest (E2V/DNG)
Number of subjects: 409
Study 23638631 — intervention group
Group type: COMPARATOR
Intervention: Ethinylestradiol/norgestimate (EE/NGM)
Number of subjects: 409
Study 22353406 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-etching sealant (Enamel Loc)
Number of subjects: 52
Study 22353406 — intervention group
Group type: COMPARATOR
Intervention: Traditional phosphoric acid-etched sealant (UltraSeal XT Plus)
Number of subjects: 52
Study 22353406 — intervention group
Group type: EXPERIMENTAL
Intervention: Saliva contamination
Number of subjects: 52
Study 19559235 — intervention group
Group type: EXPERIMENTAL
Intervention: EmBlocker (Neurosonix Ltd) activated for 1 minute (1.5 W/cm(2)) during seven selected aortic manipulations and for 10 minutes (0.5 W/cm(2)) intermittently after cross-clamp removal.
Number of subjects: 21
Study 16430436 — intervention group
Group type: EXPERIMENTAL
Intervention: galyfilcon A lenses
Number of subjects: 56
Study 16430436 — intervention group
Group type: EXPERIMENTAL
Intervention: lotrafilcon A lenses
Number of subjects: 56
Study 15499291 — intervention group
Group type: EXPERIMENTAL
Intervention: Attenuation corrected (AC) studies
Number of subjects: 500
Study 15499291 — intervention group
Group type: COMPARATOR
Intervention: Non-attenuation corrected (NAC) studies
Number of subjects: 500
Study 15499291 — intervention group
Group type: COMPARATOR
Intervention: NAC studies
Number of subjects: 500
Study 11707563 — intervention group
Group type: EXPERIMENTAL
Intervention: Liquid meal replacement containing lactose, fructose, and sucrose
Number of subjects: 75
Study 11707563 — intervention group
Group type: EXPERIMENTAL
Intervention: Liquid meal replacement with oligosaccharides (sugar-free Slim-Fast)
Number of subjects: 75
Study 11707563 — intervention group
Group type: COMPARATOR
Intervention: Exchange diet plan (EDP)
Number of subjects: 75
Study 9291756 — intervention group
Group type: EXPERIMENTAL
Intervention: Cricoid pressure
Number of subjects: 10
Study 9291756 — intervention group
Group type: EXPERIMENTAL
Intervention: Suprasternal palpation
Number of subjects: 10
Study 9291756 — intervention group
Group type: EXPERIMENTAL
Intervention: Roll test
Number of subjects: 10
Study 29752413 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus with reduced-exposure CNI
Number of subjects: 2037
Study 29752413 — intervention group
Group type: COMPARATOR
Intervention: Mycophenolic acid (MPA) with standard-exposure CNI
Number of subjects: 2037
Study 27345496 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel
Number of subjects: 0
Study 27345496 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 25210200 — intervention group
Group type: EXPERIMENTAL
Intervention: RFA followed by [(131)I] metuximab (n = 62)
Number of subjects: 127
Study 25210200 — intervention group
Group type: COMPARATOR
Intervention: RFA alone (n = 65)
Number of subjects: 127
Study 25210200 — intervention group
Group type: EXPERIMENTAL
Intervention: RFA followed by [(131)I] metuximab in CD147-positive subpopulation
Number of subjects: 127
Study 23132292 — intervention group
Group type: EXPERIMENTAL
Intervention: Pixon-processed half-count scans
Number of subjects: 150
Study 23132292 — intervention group
Group type: EXPERIMENTAL
Intervention: Half-count scans
Number of subjects: 150
Study 23132292 — intervention group
Group type: COMPARATOR
Intervention: Full-count scans
Number of subjects: 150
Study 19344226 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher FAI (Free Androgen Index)
Number of subjects: 200
Study 19344226 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower SHBG (Sex Hormone-Binding Globulin)
Number of subjects: 200
Study 19344226 — intervention group
Group type: COMPARATOR
Intervention: CVD cases
Number of subjects: 200
Study 19344226 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI adjustment
Number of subjects: 200
Study 18595488 — intervention group
Group type: EXPERIMENTAL
Intervention: Lichtenstein hernia repair
Number of subjects: 40
Study 18595488 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy males)
Number of subjects: 40
Study 15601638 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate and 5-fluorouracil (MF)
Number of subjects: 3863
Study 15601638 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide with Methotrexate and 5-fluorouracil (CMF)
Number of subjects: 3863
Study 15601638 — intervention group
Group type: COMPARATOR
Intervention: Cyclophosphamide and Doxorubicin (AC)
Number of subjects: 3863
Study 15601638 — intervention group
Group type: COMPARATOR
Intervention: CMF or AC (combined)
Number of subjects: 3863
Study 11176767 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate hydrochloride (Ritalin)
Number of subjects: 144
Study 11176767 — intervention group
Group type: EXPERIMENTAL
Intervention: Pemoline (Cylert)
Number of subjects: 144
Study 11176767 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 144
Study 11176767 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychostimulants (Methylphenidate and Pemoline combined)
Number of subjects: 144
Study 9492508 — intervention group
Group type: EXPERIMENTAL
Intervention: Low flow anesthesia (group L): oxygen 0.5 l.min‐1, nitrous oxide 0.5 l.min‐1, isoflurane
Number of subjects: 30
Study 9492508 — intervention group
Group type: COMPARATOR
Intervention: Standard flow anesthesia (group H): oxygen 2 l.min‐1, nitrous oxide 4 l.min‐1, isoflurane
Number of subjects: 30
Study 8056738 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone administration
Number of subjects: 1
Study 8056738 — intervention group
Group type: COMPARATOR
Intervention: Control sessions
Number of subjects: 1
Study 3178489 — intervention group
Group type: EXPERIMENTAL
Intervention: hGH (group 2)
Number of subjects: 19
Study 3178489 — intervention group
Group type: EXPERIMENTAL
Intervention: hGH (group 3)
Number of subjects: 19
Study 3178489 — intervention group
Group type: COMPARATOR
Intervention: Placebo (group 1)
Number of subjects: 19
Study 4204790 — intervention group
Group type: EXPERIMENTAL
Intervention: 3200 IU of vitamin E daily
Number of subjects: 55
Study 4204790 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study 4204790 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular daily dose of vitamin E (400 to 2400 IU)
Number of subjects: 55
Study 31264773 — intervention group
Group type: EXPERIMENTAL
Intervention: Labor induction at 39 weeks
Number of subjects: 0
Study 31264773 — intervention group
Group type: COMPARATOR
Intervention: Expectant management
Number of subjects: 0
Study 31264773 — intervention group
Group type: EXPERIMENTAL
Intervention: Composite of adverse neonatal outcomes
Number of subjects: 0
Study 27871723 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab added to chemotherapy
Number of subjects: 133
Study 27871723 — intervention group
Group type: COMPARATOR
Intervention: Single-agent chemotherapy alone
Number of subjects: 133
Study 27871723 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Number of subjects: 133
Study 25966138 — intervention group
Group type: EXPERIMENTAL
Intervention: Disposcope endoscope (Group D)
Number of subjects: 40
Study 25966138 — intervention group
Group type: COMPARATOR
Intervention: Macintosh laryngoscope (Group M)
Number of subjects: 40
Study 23741997 — intervention group
Group type: EXPERIMENTAL
Intervention: SRP+Er:YAG laser
Number of subjects: 30
Study 23741997 — intervention group
Group type: EXPERIMENTAL
Intervention: SRP+topical gaseous ozone
Number of subjects: 30
Study 23741997 — intervention group
Group type: COMPARATOR
Intervention: SRP alone
Number of subjects: 30
Study 21273939 — intervention group
Group type: EXPERIMENTAL
Intervention: HPV‐16/18 vaccine administered according to the alternative schedule (0‐1‐12 months)
Number of subjects: 804
Study 21273939 — intervention group
Group type: COMPARATOR
Intervention: HPV‐16/18 vaccine administered according to the standard schedule (0‐1‐6 months)
Number of subjects: 804
Study 18971567 — intervention group
Group type: EXPERIMENTAL
Intervention: ICD implantation with limited induction of ventricular fibrillation (VF)
Number of subjects: 16
Study 18971567 — intervention group
Group type: EXPERIMENTAL
Intervention: ICD implantation with limited induction of VF
Number of subjects: 16
Study 17633249 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal operation (septoplasty, radiofrequency reduction of inferior turbinate, adenoidectomy, functional endoscopic operation)
Number of subjects: 88
Study 17633249 — intervention group
Group type: EXPERIMENTAL
Intervention: UPPP (Uvulopalatopharyngoplasty)
Number of subjects: 88
Study 17633249 — intervention group
Group type: COMPARATOR
Intervention: UPPP
Number of subjects: 88
Study 17633249 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal operation (second phase for group B)
Number of subjects: 88
Study 15205983 — intervention group
Group type: EXPERIMENTAL
Intervention: Video colposcopy
Number of subjects: 60
Study 15205983 — intervention group
Group type: COMPARATOR
Intervention: Regular colposcopy
Number of subjects: 60
Study 11913307 — intervention group
Group type: EXPERIMENTAL
Intervention: Baking soda-containing chewing gum (AHDC)
Number of subjects: 126
Study 11913307 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental gum formulations
Number of subjects: 126
Study 9286747 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium supplements (mean calcium dose: 1050 mg)
Number of subjects: 14
Study 9286747 — intervention group
Group type: COMPARATOR
Intervention: Dietary calcium
Number of subjects: 14
Study 7950469 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational sessions for physicians to standardize knowledge of the recommendations of the Canadian Hypertension Society on hypertension treatment and specific operational incentives to improve hypertension control.
Number of subjects: 200
Study 7950469 — intervention group
Group type: COMPARATOR
Intervention: Control Group A (100 patients before and after)
Number of subjects: 200
Study 7950469 — intervention group
Group type: COMPARATOR
Intervention: Control Group B (60 patients before and after)
Number of subjects: 200
Study 7950469 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients listed in the recall card file
Number of subjects: 200
Study 2438648 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 ABVD chemotherapy
Number of subjects: 120
Study 2438648 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 Gy radiotherapy
Number of subjects: 120
Study 2438648 — intervention group
Group type: COMPARATOR
Intervention: Not specified
Number of subjects: 120
Study 30549271 — intervention group
Group type: EXPERIMENTAL
Intervention: Piezosurgery (PS)
Number of subjects: 14
Study 30549271 — intervention group
Group type: COMPARATOR
Intervention: Conventional drill
Number of subjects: 14
Study 30549271 — intervention group
Group type: EXPERIMENTAL
Intervention: Piezosurgery (PS) and Conventional drill
Number of subjects: 14
Study 28718232 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous steroids (120 mg of injection Depomedrol) administered 1 hour before surgery
Number of subjects: 65
Study 28718232 — intervention group
Group type: COMPARATOR
Intervention: Conventional MRM without steroids (Group A)
Number of subjects: 65
Study 25454942 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled nitric oxide (iNO)
Number of subjects: 55
Study 25454942 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study 23843375 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteopathic manipulative treatment (OMT) protocol consisting of myofascial release to the thoracic inlet, the splenic pump, and the pedal lymphatic pump for 6 minutes.
Number of subjects: 20
Study 23843375 — intervention group
Group type: COMPARATOR
Intervention: Light touch protocol applied to the same body areas for 6 minutes.
Number of subjects: 20
Study 23843375 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteopathic manipulative treatment (OMT) protocol
Number of subjects: 20
Study 21926038 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryosurgery during daily imiquimod application (Arm I)
Number of subjects: 16
Study 21926038 — intervention group
Group type: COMPARATOR
Intervention: Adjuvant imiquimod (Arm II)
Number of subjects: 16
Study 19183841 — intervention group
Group type: EXPERIMENTAL
Intervention: Nateglinide
Number of subjects: 0
Study 19183841 — intervention group
Group type: COMPARATOR
Intervention: Repaglinide
Number of subjects: 0
Study 16924022 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxcarbazepine
Number of subjects: 0
Study 16924022 — intervention group
Group type: COMPARATOR
Intervention: Carbamazepine/Valproate
Number of subjects: 0
Study 15492493 — intervention group
Group type: EXPERIMENTAL
Intervention: Present group (current patients)
Number of subjects: 175
Study 15492493 — intervention group
Group type: COMPARATOR
Intervention: Past group (patients from 15 years ago)
Number of subjects: 175
Study 15492493 — intervention group
Group type: EXPERIMENTAL
Intervention: Children aged 6 or younger in the present group
Number of subjects: 175
Study 15492493 — intervention group
Group type: EXPERIMENTAL
Intervention: Children aged 7 or older in both groups
Number of subjects: 175
Study 11533366 — intervention group
Group type: EXPERIMENTAL
Intervention: Montelukast 4 mg chewable tablet
Number of subjects: 689
Study 11533366 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 689
Study 9506726 — intervention group
Group type: EXPERIMENTAL
Intervention: Levothyroxine (L‐T4) suppressive therapy
Number of subjects: 83
Study 9506726 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 83
Study 8172437 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluconazole, 150 mg, once daily
Number of subjects: 820
Study 8172437 — intervention group
Group type: COMPARATOR
Intervention: Oral amphotericin B, 500 mg every 6 hours
Number of subjects: 820
Study 3168767 — intervention group
Group type: EXPERIMENTAL
Intervention: Beer drinking group
Number of subjects: 20
Study 3168767 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 20
Study 31880956 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomised study design
Number of subjects: 0
Study 31880956 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental design
Number of subjects: 0
Study 31072385 — intervention group
Group type: EXPERIMENTAL
Intervention: Compliant regular users (C-RU) of advanced PAP therapy
Number of subjects: 96
Study 31072385 — intervention group
Group type: EXPERIMENTAL
Intervention: Subthreshold users (SC-RU) of advanced PAP therapy
Number of subjects: 96
Study 31072385 — intervention group
Group type: COMPARATOR
Intervention: Noncompliant users (NC-MU) of advanced PAP therapy
Number of subjects: 96
Study 31072385 — intervention group
Group type: EXPERIMENTAL
Intervention: Hours of weekly PAP use
Number of subjects: 96
Study 30066463 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-month support programme consisting of psychoeducation, social support, and behavioural cognitive therapy
Number of subjects: 30
Study 30066463 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention details provided)
Number of subjects: 30
Study 25714035 — intervention group
Group type: EXPERIMENTAL
Intervention: Green tea consumption
Number of subjects: 8
Study 25714035 — intervention group
Group type: EXPERIMENTAL
Intervention: Black tea consumption
Number of subjects: 8
Study 25141110 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.0 W/cm2 continuous ultrasound treatment
Number of subjects: 46
Study 25141110 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.0 W/cm2 1:4 pulsed ultrasound treatment
Number of subjects: 46
Study 25141110 — intervention group
Group type: COMPARATOR
Intervention: 0 W/cm2 ultrasound treatment (placebo)
Number of subjects: 46
Study 21707451 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil (FO) supplementation, 2 g/day for 15 days
Number of subjects: 0
Study 21707451 — intervention group
Group type: COMPARATOR
Intervention: Primrose oil (PO) supplementation (control)
Number of subjects: 0
Study 18973889 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose oral contraceptive containing ethinyl estradiol and drospirenone for three cycles
Number of subjects: 20
Study 17207126 — intervention group
Group type: EXPERIMENTAL
Intervention: Assertive Continuing Care (ACC)
Number of subjects: 183
Study 17207126 — intervention group
Group type: COMPARATOR
Intervention: Usual Continuing Care (UCC)
Number of subjects: 183
Study 16395988 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin glargine in combination with oral antidiabetic drugs (OADs)
Number of subjects: 678
Study 16395988 — intervention group
Group type: COMPARATOR
Intervention: Conventional insulin therapy
Number of subjects: 678
Study 16395988 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin glargine plus OADs
Number of subjects: 678
Study 12475159 — intervention group
Group type: EXPERIMENTAL
Intervention: Welded titanium frameworks
Number of subjects: 58
Study 12475159 — intervention group
Group type: COMPARATOR
Intervention: Conventional cast-gold alloy frameworks
Number of subjects: 58
Study 12475159 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 58
Study 9893589 — intervention group
Group type: EXPERIMENTAL
Intervention: ICSC
Number of subjects: 34
Study 9893589 — intervention group
Group type: EXPERIMENTAL
Intervention: POAG
Number of subjects: 34
Study 9893589 — intervention group
Group type: COMPARATOR
Intervention: Normal subjects
Number of subjects: 34